Matches in SemOpenAlex for { <https://semopenalex.org/work/W2916443575> ?p ?o ?g. }
- W2916443575 endingPage "1815" @default.
- W2916443575 startingPage "1798" @default.
- W2916443575 abstract "Mycobacterium tuberculosis, the etiologic agent of tuberculosis, is an intracellular pathogen of alveolar macrophages. These cells avidly take up nanoparticles, even without the use of specific targeting ligands, making the use of nanotherapeutics ideal for the treatment of such infections. Methoxy poly(ethylene oxide)-block-poly(ε-caprolactone) nanoparticles of several different polymer blocks’ molecular weights and sizes (20–110 nm) were developed and critically compared as carriers for rifampicin, a cornerstone in tuberculosis therapy. The polymeric nanoparticles’ uptake, consequent organelle targeting and intracellular degradation were shown to be highly dependent on the nanoparticles’ physicochemical properties (the cell uptake half-lives 2.4–21 min, the degradation half-lives 51.6 min–ca. 20 h after the internalization). We show that the nanoparticles are efficiently taken up by macrophages and are able to effectively neutralize the persisting bacilli. Finally, we demonstrate, using a zebrafish model of tuberculosis, that the nanoparticles are well tolerated, have a curative effect, and are significantly more efficient compared to a free form of rifampicin. Hence, these findings demonstrate that this system shows great promise, both in vitro and in vivo, for the treatment of tuberculosis." @default.
- W2916443575 created "2019-03-02" @default.
- W2916443575 creator A5002421851 @default.
- W2916443575 creator A5005241184 @default.
- W2916443575 creator A5008024857 @default.
- W2916443575 creator A5014906346 @default.
- W2916443575 creator A5025689465 @default.
- W2916443575 creator A5026986429 @default.
- W2916443575 creator A5042337581 @default.
- W2916443575 creator A5043955960 @default.
- W2916443575 creator A5046616086 @default.
- W2916443575 creator A5047489056 @default.
- W2916443575 creator A5055987329 @default.
- W2916443575 creator A5057069583 @default.
- W2916443575 creator A5057591029 @default.
- W2916443575 creator A5071217727 @default.
- W2916443575 creator A5083890674 @default.
- W2916443575 creator A5084636593 @default.
- W2916443575 date "2019-02-20" @default.
- W2916443575 modified "2023-10-15" @default.
- W2916443575 title "Rifampicin Nanoformulation Enhances Treatment of Tuberculosis in Zebrafish" @default.
- W2916443575 cites W1780836844 @default.
- W2916443575 cites W1971065423 @default.
- W2916443575 cites W1977149116 @default.
- W2916443575 cites W1978654303 @default.
- W2916443575 cites W1979740290 @default.
- W2916443575 cites W1984699742 @default.
- W2916443575 cites W1986065235 @default.
- W2916443575 cites W1986849434 @default.
- W2916443575 cites W1991767480 @default.
- W2916443575 cites W1993119420 @default.
- W2916443575 cites W1993468104 @default.
- W2916443575 cites W1998631074 @default.
- W2916443575 cites W2002897817 @default.
- W2916443575 cites W2005668670 @default.
- W2916443575 cites W2007080834 @default.
- W2916443575 cites W2020779026 @default.
- W2916443575 cites W2020967076 @default.
- W2916443575 cites W2021068830 @default.
- W2916443575 cites W2030785278 @default.
- W2916443575 cites W2032468019 @default.
- W2916443575 cites W2032886124 @default.
- W2916443575 cites W2037818300 @default.
- W2916443575 cites W2038864652 @default.
- W2916443575 cites W2044363921 @default.
- W2916443575 cites W2051034485 @default.
- W2916443575 cites W2056255338 @default.
- W2916443575 cites W2061177902 @default.
- W2916443575 cites W2070395891 @default.
- W2916443575 cites W2070885544 @default.
- W2916443575 cites W2073771282 @default.
- W2916443575 cites W2076894650 @default.
- W2916443575 cites W2083964174 @default.
- W2916443575 cites W2091760375 @default.
- W2916443575 cites W2093150620 @default.
- W2916443575 cites W2096196478 @default.
- W2916443575 cites W2100807825 @default.
- W2916443575 cites W2109431702 @default.
- W2916443575 cites W2115434346 @default.
- W2916443575 cites W2129922679 @default.
- W2916443575 cites W2145364955 @default.
- W2916443575 cites W2149287854 @default.
- W2916443575 cites W2154439517 @default.
- W2916443575 cites W2155118487 @default.
- W2916443575 cites W2162528235 @default.
- W2916443575 cites W2162948201 @default.
- W2916443575 cites W2164474259 @default.
- W2916443575 cites W2192049920 @default.
- W2916443575 cites W2217705519 @default.
- W2916443575 cites W2278869839 @default.
- W2916443575 cites W2322473086 @default.
- W2916443575 cites W2337917444 @default.
- W2916443575 cites W2412063266 @default.
- W2916443575 cites W2516007550 @default.
- W2916443575 cites W2532005031 @default.
- W2916443575 cites W2614363750 @default.
- W2916443575 cites W2615185438 @default.
- W2916443575 cites W2624317658 @default.
- W2916443575 cites W2726126485 @default.
- W2916443575 cites W2743312496 @default.
- W2916443575 cites W2763213386 @default.
- W2916443575 cites W2769918223 @default.
- W2916443575 cites W2775204995 @default.
- W2916443575 cites W2780354128 @default.
- W2916443575 cites W2791214549 @default.
- W2916443575 cites W2807919944 @default.
- W2916443575 cites W2884173047 @default.
- W2916443575 cites W2886998885 @default.
- W2916443575 cites W4238314033 @default.
- W2916443575 doi "https://doi.org/10.1021/acs.biomac.9b00214" @default.
- W2916443575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30785284" @default.
- W2916443575 hasPublicationYear "2019" @default.
- W2916443575 type Work @default.
- W2916443575 sameAs 2916443575 @default.
- W2916443575 citedByCount "27" @default.
- W2916443575 countsByYear W29164435752019 @default.
- W2916443575 countsByYear W29164435752020 @default.
- W2916443575 countsByYear W29164435752021 @default.